By The Petrie-Flom Center THE NORTHEASTERN PROGRAM ON HEALTH POLICY & LAW PRESENTS: HIV/AIDS Policy Grand Rounds: Drug Use and HIV: A Tale of Toxic Law In the wake of the HIV epidemic, legal and policy tools became critical in combatting the epidemic. The HIV/AIDS Policy Grand Rounds is an interdisciplinary series of workshops designed to…
By Anup Malani In my second post, I want continue my discussion of reverse settlements. Recall that the basic argument against reverse settlements is that they extend the duration of a pioneer drug company’s patent beyond what it might expected to be if there were no settlement. (Elhauge and Krueger (Texas Law Review, 2012) have…
By Anup Malani Before I begin my initial post, I want to thank Holly for inviting me to post on this blog. I want to take up reverse settlements in litigation over pharmaceutical patents. Circuits are divided on how to treat these settlements under antitrust law (Elhauge & Krueger, Texas L. Rev., 91:283, 285, 2012). …
By Temple University Center for Public Health Law Research This past week, PHLR hosted 150 researchers, lawyers, public health practitioners and others for our fourth annual meeting. With our theme for the conference in mind, “Driving Legal Innovation,” our attendees shared results of evaluations of laws and regulations, offered up suggestions for new ways to…
By Michelle Meyer So, one thing they say about being on the law teaching market is that you likely will never before have enjoyed — and, less happily, will likely never again enjoy — so much attention to your work and so many opportunities to discuss it. That’s totally true, and it’s totally fabulous. But there’s…
By Katie Booth In the Supreme Court’s recent decision in Auburn Regional Medical Center, the Court held that a suit against HHS by eighteen hospitals alleging intentional underpayment of Medicare reimbursements was barred by a 180-day internal agency deadline for appeals of reimbursement decisions. The rub is that the hospitals only found out about the…
By Yoni Schenker This past September, I had the unfortunate and ironic experience of transitioning from conducting research on the American healthcare system to being a patient in the American healthcare system. In September, I was diagnosed with testicular cancer, while working as a research assistant for Professor Einer Elhauge, scouring the Affordable Care Act…
By Adriana Lee Benedict In a couple days, petitioners in AMP v. USPTO will be filing their brief on the merits following the Supreme Court’s grant of certiorari in late November. For many, the Supreme Court’s ruling in this case will provide a long-awaited answer to the question of whether or not isolated DNA is…
Governance of Tobacco in the 21st Century: Strengthening National and International Policy for Global Health and Development February 26-27, 2013 Harvard University, Cambridge, MA, USA Keynote Speakers: Dr. Nkosazana Dlamini-Zuma Chairperson, African Union Commission Dr. Margaret Chan Director-General, World Health Organization How do international laws and institutions regarding tobacco, trade, investment, agriculture and economic development…
By Elizabeth Sepper 2013 is rife with reports of the terrible human costs of the flu. Emergency rooms nationwide have been overwhelmed. Art Caplan’s great blog post urges doctors to educate patients that the flu vaccine is not just for their benefit. He tells healthcare providers to send a clear message by getting the flu…
